Figure 3.
Course of clinical and endoscopic activity indices (CAI, EI) throughout the apheresis treatment. aP<0.05 vs Et at wk 6, bP<0.01 vs Et at wk 5, dP<0.01 vs Et at wk 4, fP<0.05 vs Et at wk 3.
Course of clinical and endoscopic activity indices (CAI, EI) throughout the apheresis treatment. aP<0.05 vs Et at wk 6, bP<0.01 vs Et at wk 5, dP<0.01 vs Et at wk 4, fP<0.05 vs Et at wk 3.